Secondary oxalosis: A cause of delayed recovery of renal function in the setting of acute renal failure

Journal of the American Society of Nephrology

Volumn 7, Issue 11, 1996, Pages 2320-2326

  Alkhunaizi, Ahmed M ^a   Chan, Laurence ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Acute renal failure; Acute tubular necrosis; Oxalic acid; Oxalosis; Vitamin C

Indexed keywords

AMIKACIN; ASCORBIC ACID; CALCIUM OXALATE; CREATININE; NITROGEN; PENTETATE TECHNETIUM TC 99M; UREA;

ACUTE KIDNEY FAILURE; ADULT; ANURIA; ARTICLE; BURN; CASE REPORT; DIALYSIS; DRUG OVERDOSE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY SCINTISCANNING; MALE; MICROSCOPY; OXALOSIS; PRIORITY JOURNAL; SUPPLEMENTATION; TOTAL PARENTERAL NUTRITION; URINALYSIS;

EID: 0030357277     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Danpure CJ, Jennings PR: Peroxisomal alanine: Glyoxylate aminotransferase in primary hyperoxaluria type 1. FEBS Lett 1986;201:20-24.
2. Chlebeck PT, Milliner DS, Smith LH: Long-term prognosis in primary hyperoxaluria type II. Am J Kidney Dis 1994;23:255-259.
3. De Zegher FE, Wolff ED, vd Heijden AJ, Sukhai RN: Oxalosis in infancy. Clin Nephrol 1984;22:114-120.
4. Leumann EP: Primary hyperoxaluria: An important cause of renal failure in infancy. Int J Pediatr Nephrol 1985;6:13-16.
5. Leumann EP, Niederwieser A, Fanconi A: New aspects of infantile oxalosis. Pediatr Nephrol 1987;1:531-535.
6. Morgan SH, Watts RW: Prespectives in the assessment and management of patients with primary hyperoxaluria type I. Adv Nephrol Necker Hosp 1989;18:95-106.
7. Toussaint C, Goffin Y, Potvliege P, et al.: Kidney transplantation in primary oxalosis. Clin Nephrol 1976;5: 239-244.
8. Scheinman JI, Najarian JS, Mauer SM: Successful strategies for renal transplantation in primary oxalosis. Kidney Int 1984;25:804-811.
9. Katz A, Freese D, Danpure CJ, Scheinman JI, Mauer SM: Success of kidney transplantation in oxalosis is unrelated to residual hepatic enzyme activity. Kidney Int 1992;42:1408-411.
10. Watts RW, Calne RY, Rolles K, et al.: Successful treatment of primary hyperoxaluria type I by combined hepatic and renal transplantation. Lancet 1987;2:474-475.
11. Janssen F, Hall M, Schurmans T, et al.: Combined Liver and kidney transplantation in primary hyperoxaluria type I in children. Transplant Proc 1994;26:110-111.
12. Bufi M, Rossi A, Costa MG, et al.: A case report of combined liver-kidney transplantation. Tansplant Proc 1994;26:3645-3646.
13. Conger JD: Does hemodialysis delay recovery from acute renal failure? Semin Dial 1990;3:146.
14. Baker EM, Saari JC, Tolbert BM: Ascorbic acid metabolism in man. Am J Clin Nutr 1966;19:371-378.
15. Sullivan JF, Eisenstein AB, Mottola OM, Mittal AK: The effect of dialysis on plasma and tissue levels of vitamin C. Trans Am Soc Artif Intern Organs 1972;18:277-282.
16. Pönkä A, Kuhlback B: Serum ascorbic acid in patients undergoing chronic hemodialysis. Acta Med Scand 1983;213:305-307.
17. The Nutritional Research Council. Recommended Dietary Allowance: 1980, 9th Ed. Washington, DC: National Academy of Sciences; 1980.
18. Sullivan JF, Eisenstein AB: Ascorbic acid depletion in patients undergoing chronic hemodialysis. Am J Clin Nutr 1970;23:1339-1346.
19. Pru C, Eaton J, Kjellstrand C: Vitamin C intoxication and hyperoxalemia in chronic hemodialysis patients. Nephron 1985;39:112-116.
20. Balcke P, Schmidt P, Zazgornik J, Kopsa H, Haubenstock A: Ascorbic acid aggravates secondary hyperoxalemia in patients on chronic hemodialysis. Ann Intern Med 1984;101:344-345.
21. Blacke P, Schmidt P, Zazgornik J, Kopsa H, Deutsch E: Secondary oxalosis in chronic renal insufficiency. N Engl J Med 1980;303:944.
22. Wandzilak TR, D'Andre SD, Davis PA, Williams HE: Effect of high dose vitamin C on urinary oxalate levels. J Urology 1994;151:834-837.
23. Saunders DR, Sillery J, McDonalds GB: Regional differences in oxalate absorption by rat intestine: evidence for excessive absorption by the colon in steatorrhoea. Gut 1975;16:543-554.
24. Knickelbein RG, Aronson PS, Dobbins JW: Oxalate transport by anion exchange across rabbit ileal brush border. J Clin Invest 1986;77:170-175.
25. Smith LH, Fromm H, Hofmann AF: Acquired hyperoxaluria, nephrolithiasis and intestinal disease. Description of a syndrome. N Engl J Med 1972;286:1371-1375.
26. Drenick EJ, Stanley TM, Border WA, et al.: Renal damage with intestinal bypass. Ann Intern Med 1978;89: 594-599.
27. Rampton DS, Sarner M: Enteric and other secondary hyperoxalurias. In: Rose, ed. Oxalate Metabolism In Relation To Urinary Stones. London: Springer/Verlag; 1988:103-120.
28. Cattell WR, Spencer AG, Taylor GW, Watts RW: The mechanism of the renal excretion of oxalate in the dog. Clin Sci 1962;22:43-52.
29. Weinman EJ, Frankfurt SJ, Ince A, Sansom S: Renal tubular transport of organic acids. Studies with oxalate and para-aminohippurate in the rat. J Clin Invest 1978; 61:801-806.
30. Kelly CJ, Neilson EG: Tubulointerstitial diseases. In: Brenner & Rector's, The Kidney, 5th ed. Philadelphia: Saunders; 1995:1655-1679.
31. Lieske JC, Walsh-Reitz MM, Toback FG: Calcium oxalate monohydrate crystals are endocytosed by renal epithelial cells and induce proliferation. Am J Physiol 1992;262:F622-F630.
32. Lieske JC, Swift H, Martin T, Patterson B, Toback FG: Renal epithelial cells rapidly bind and internalize calcium oxalate monohydrate crystals. Proc Natl Acad Sci USA 1994;91:6987-6991.
33. Hammes MS, Lieske JC, Pawar S, Spargo BH, Toback FG: Calcium oxalate monohydrate crystals stimulate gene expression in renal epithelial cells. Kidney Int 1995;48:501-509.
34. Bove KE: Ethylene glycol toxicity. Am J Clin Pathol 1966;45:46-50.
35. Bergstrand A, Collste LG, Franksson C, et al.: Oxalosis in renal transplant following methoxyflurane anaesthesia. Br J Anaesth 1972;44:569-574.
36. Mazze RI, Shue GL, Jackson SH: Renal dysfunction associated with methoxyflurane anesthesia. JAMA 1971;216:278-288.
37. Swartz RD, Wesley JR, Somermeyer MG, Lau K: Hyperoxaluria and renal insufficiency due to ascorbic acid administration during total parenteral nutrition. Ann Intern Med 1984;100:530-531.
38. Wong K, Thomson C, Bailey RR, McDiarmid S, Gardner J: Acute oxalate nephropathy after a massive intravenous dose of vitamin C. Aust NZ J Med 1994;24:410-411.
39. Lawton JM, Conway LT, Crosson JT, Smith CL, Abraham PA: Acute oxalate nephropathy after massive ascorbic acid administration. Arch Intern Med 1985; 145:950-951.
40. Friedman AL, Chesney RW, Gilbert EF, Gilchrist KW, Latorraca R, Segar WE: Secondary oxalosis as a complication of parenteral alimentation in acute renal failure. Am J Nephrol 1983;3:248-252.
41. Salyer WR, Keren D: Oxalosis as a complication of chronic renal failure. Kidney Int 1973;4:61-66.
42. Salyer WR, Hutchins GM: Cardiac lesions in secondary oxalosis. Arch Intern Med 1974;134:250-252.
43. Fayemi AO, Ali M, Braun EV: Oxalosis in hemodialysis patients: A pathologic study of 80 cases. Arch Pathol Lab Med 1979;103:58-62.
44. Hoffman GS, Schumacher HR, Paul H, et al.: Calcium oxalate microcrystalline-associated arthritis in end-stage renal disease. Ann Intern Med 1982;97:36-42.
45. Reginato AJ, Ferreiro-Seoane JL, Barbazan-Alvarez C, et al.: Arthropathy and cutaneous calcinosis in hemodialysis oxalosis. Arthritis Rheum 1986;29:1387-1396.
46. Julian BA, Faugere MC, Malluche HH: Oxalosis in bone causing a radiographical mimicry of renal osteodystrophy. Am J Kidney Dis 1987;9:436-440.